Common mechanisms of pain and depression: Are antidepressants also analgesics?

Frontiers in Behavioral Neuroscience

Volumn 8, Issue MAR, 2014, Pages

  Nekovarova, Tereza ^a,b   Yamamotova, Anna ^b   Vales, Karel ^a   Stuchlik, Ales ^a   Fricova, Jitka ^c   Rokyta, Richard ^b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antidepressants; Chronic pain; Cytokines; Default mode network; Depression; Neuroplasticity; Stress

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE;

ARTICLE; CHRONIC PAIN; COGNITION; COMORBIDITY; DEFAULT MODE NETWORK; DEPRESSION; DISEASE ASSOCIATION; EMOTION; HUMAN; INTROSPECTION; MENTAL PERFORMANCE; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; QUALITY OF LIFE;

EID: 84896999945     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00099     Document Type: Article

References (168)

1. Alexopoulos, G. S., Hoptman, M. J., Kanellopoulos, D., Murphy, C. F., Lim, K. O., and Gunning, F. M. (2012). Functional connectivity in the cognitive control network and the default mode network in late-life depression. J. Affect. Disord. 139, 56-65. doi: 10.1016/j.jad.2011.12.002
2. Altier, N., and Stewart, J. (1999). The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 65, 2269-2287. doi: 10.1016/s0024-3205(99)00298-2
3. Amado-Boccara, I., Gougoulis, N., Poirier Littré, M. F., Galinowski, A., and Lôo, H. (1995). Effects of antidepressants on cognitive functions: a review. Neurosci. Biobehav. Rev. 19, 479-493. doi: 10.1016/0149-7634(94)00068-c
4. Andreescu, C., Tudorascu, D. L., Butters, M. A., Tamburo, E., Patel, M., Price, J., et al. (2013). Resting state functional connectivity and treatment response in late-life depression. Psychiatry Res. 214, 313-321. doi: 10.1016/j.pscychresns.2013.08.007
5. Andrews-Hanna, J. R. (2012). The brain's default network and its adaptive role in internal mentation. Neuroscientist 18, 251-270. doi: 10.1177/1073858411403316
6. Apkarian, A. V. (2008). Pain perception in relation to emotional learning. Curr. Opin. Neurobiol. 18, 464-468. doi: 10.1016/j.conb.2008.09.012
7. Apkarian, A. V. (2011). The brain in chronic pain: clinical implications. Pain Manag. 1, 577-586. doi: 10.2217/pmt.11.53
8. Apkarian, A. V., Baliki, M. N., and Geha, P. Y. (2009). Towards a theory of chronic pain. Prog. Neurobiol. 87, 81-97. doi: 10.1016/j.pneurobio.2008.09.018
9. Arnone, D., McKie, S., Elliott, R., Juhasz, G., Thomas, E. J., Downey, D., et al. (2013). State-dependent changes in hippocampal grey matter in depression. Mol. Psychiatry 18, 1265-1272. doi: 10.1038/mp.2012.150
10. Asberg, M., Träskman, L., and Thorén, P. (1976). 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch. Gen. Psychiatry 33, 1193-1197. doi: 10.1001/archpsyc.1976.01770100055005
11. Austin, M. P., Mitchell, P., and Goodwin, G. M. (2001). Cognitive deficits in depression: possible implications for functional neuropathology. Br. J. Psychiatry 178, 200-206. doi: 10.1192/bjp.178.3.200
12. Badr, H., and Shen, M. J. (2014). Pain catastrophizing, pain intensity and dyadic adjustment influence patient and partner depression in metastatic breast cancer. Clin. J. Pain doi: 10.1097/ajp.0000000000000058. [Epub ahead of print].
13. Bai, Y. M., Chiou, W. F., Su, T. P., Li, C. T., and Chen, M. H. (2014). Pro-inflammatory cytokine associated with somatic and pain symptoms in depression. J. Affect. Disord. 155, 28-34. doi: 10.1016/j.jad.2013.10.019
14. Baliki, M. N., Geha, P. Y., Apkarian, A. V., and Chialvo, D. R. (2008). Beyond feeling: chronic pain hurts the brain, disrupting the default-mode network dynamics. J. Neurosci. 28, 1398-1403. doi: 10.1523/jneurosci.4123-07.2008
15. Bandschapp, O., Filitz, J., Urwyler, A., Koppert, W., and Ruppen, W. (2011). Tropisetron blocks analgesic action of acetaminophen: a human pain model study. Pain 152, 1304-1310. doi: 10.1016/j.pain.2011.02.003
16. Barbon, A., Caracciolo, L., Orlandi, C., Musazzi, L., Mallei, A., La Via, L., et al. (2011). Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels. Neurochem. Int. 59, 896-905. doi: 10.1016/j.neuint.2011.07.013
17. Baudino, B., D'agata, F., Caroppo, P., Castellano, G., Cauda, S., Manfredi, M., et al. (2012). The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients. Q. J. Nucl. Med. Mol. Imaging 56, 559-568.
18. Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., et al. (2000). Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351-354. doi: 10.1016/s0006-3223(99)00230-9
19. Berton, O., McClung, C. A., Dileone, R. J., Krishnan, V., Renthal, W., Russo, S. J., et al. (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311, 864-868. doi: 10.1126/science.1120972
20. Bielecka, A. M., and Obuchowicz, E. (2013). Antidepressant drugs as a complementary therapeutic strategy in cancer. Exp. Biol. Med. (Maywood) 238, 849-858. doi: 10.1177/1535370213493721
21. Blackburn-Munro, G., and Blackburn-Munro, R. (2003). Pain in the brain: are hormones to blame? Trends Endocrinol. Metab. 14, 20-27. doi: 10.1016/s1043-2760(02)00004-8
22. Blackburn-Munro, G., and Blackburn-Munro, R. E. (2001). Chronic pain, chronic stress and depression: coincidence or consequence? J. Neuroendocrinol. 13, 1009-1023. doi: 10.1046/j.0007-1331.2001.00727.x
23. Blaudszun, G., Lysakowski, C., Elia, N., and Tramèr, M. R. (2012). Effect of perioperative systemic α2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials. Anesthesiology 116, 1312-1322. doi: 10.1097/ALN.0b013e31825681cb
24. Bodnoff, S. R., Humphreys, A. G., Lehman, J. C., Diamond, D. M., Rose, G. M., and Meaney, M. J. (1995). Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity and hippocampal neuropathology in young and mid-aged rats. J. Neurosci. 15, 61-69.
25. Bohren, Y., Tessier, L. H., Megat, S., Petitjean, H., Hugel, S., Daniel, D., et al. (2013). Antidepressants suppress neuropathic pain by a peripheral β2-adrenoceptor mediated anti-TNFα mechanism. Neurobiol. Dis. 60, 39-50. doi: 10.1016/j.nbd.2013.08.012
26. Bondy, B., Baghai, T. C., Minov, C., Schüle, C., Schwarz, M. J., Zwanzger, P., et al. (2003). Substance P serum levels are increased in major depression: preliminary results. Biol. Psychiatry 53, 538-542. doi: 10.1016/s0006-3223(02)01544-5
27. Booij, L., Van der Does, A. J. W., and Riedel, W. J. (2003). Monoamine depletion in psychiatric and healthy populations: review. Mol. Psychiatry 8, 951-973. doi: 10.1038/sj.mp.4001423
28. Booij, L., Van der Does, A. J., Haffmans, P. M., Riedel, W. J., Fekkes, D., and Blom, M. J. (2005). The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients. J. Psychopharmacol. 19, 267-275. doi: 10.1177/0269881105051538
29. Breitbart, W., Rosenfeld, B., Tobias, K., Pessin, H., Ku, G. Y., Yuan, J., et al. (2014). Depression, cytokines, and pancreatic cancer. Psychooncology 23, 339-345. doi: 10.1002/pon.3422
30. Browne, C. A., and Lucki, I. (2013). Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front. Pharmacol. 4:161. doi: 10.3389/fphar.2013.00161
31. Campbell, L. C., Clauw, D. J., and Keefe, F. J. (2003). Persistent pain and depression: a biopsychosocial perspective. Biol. Psychiatry 54, 399-409. doi: 10.1016/s0006-3223(03)00545-6
32. Carballedo, A., Scheuerecker, J., Meisenzahl, E., Schoepf, V., Bokde, A., Möller, H. J., et al. (2011). Functional connectivity of emotional processing in depression. J. Affect. Disord. 134, 272-279. doi: 10.1016/j.jad.2011.06.021
33. Castaneda, A. E., Tuulio-Henriksson, A., Marttunen, M., Suvisaari, J., and Lönnqvist, J. (2008). A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J. Affect. Disord. 106, 1-27. doi: 10.1016/j.jad.2007.06.006
34. Cauda, F., Torta, D. M. E., Sacco, K., Geda, E., D'Agata, F., Costa, T., et al. (2012). Shared "core" areas between the pain and other task-related networks. PLoS One 7:e41929. doi: 10.1371/journal.pone.0041929
35. Chapman, C. R., Tuckett, R. P., and Song, C. W. (2008). Pain and stress in a systems perspective: reciprocal neural, endocrine and immune interactions. J. Pain 9, 122-145. doi: 10.1016/j.jpain.2007.09.006
36. Chatzittofis, A., Nordström, P., Hellström, C., Arver, S., Åsberg, M., and Jokinen, J. (2013). CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters. Eur. Neuropsychopharmacol. 23, 1280-1287. doi: 10.1016/j.euroneuro.2013.02.002
37. Chou, K. L. (2007). Reciprocal relationship between pain and depression in older adults: evidence from the English longitudinal study of ageing. J. Affect. Disord. 102, 115-123. doi: 10.1016/j.jad.2006.12.013
38. Connor, T. J., and Leonard, B. E. (1998). Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci. 62, 583-606. doi: 10.1016/s0024-3205(97)00990-9
39. Delgado, P. L., and Moreno, F. A. (2000). Role of norepinephrine in depression. J. Clin. Psychiatry 61(Suppl. 1), 5-12.
40. Dowben, J. S., Grant, J. S., and Keltner, N. L. (2013). Ketamine as an alternative treatment for treatment-resistant depression. Perspect. Psychiatr. Care 49, 2-4. doi: 10.1111/ppc.12006
41. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., et al. (2010). A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446-457. doi: 10.1016/j.biopsych.2009.09.033
42. Fang, C. K., Chen, H. W., Chiang, I. T., Chen, C. C., Liao, J. F., Su, T. P., et al. (2012). Mirtazapine inhibits tumor growth via immune response and serotonergic system. PLoS One 7:e38886. doi: 10.1371/journal.pone.0038886
43. Farmer, M. A., Baliki, M. N., and Apkarian, A. V. (2012). A dynamic network perspective of chronic pain. Neurosci. Lett. 520, 197-203. doi: 10.1016/j.neulet.2012.05.001
44. Farooqui, M., Li, Y., Rogers, T., Poonawala, T., Griffin, R. J., Song, C. W., et al. (2007). COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br. J. Cancer 97, 1523-1531. doi: 10.1038/sj.bjc.6604057
45. Fields, H. L., Heinricher, M. M., and Mason, P. (1991). Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 14, 219-245. doi: 10.1146/annurev.ne.14.030191.001251
46. Finsterwald, C., and Alberini, C. M. (2013). Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: from adaptive responses to psychopathologies. Neurobiol. Learn. Mem. doi: 10.1016/j.nlm.2013.09.017. [Epub ahead of print].
47. Fox, A., Medhurst, S., Courade, J. P., Glatt, M., Dawson, J., Urban, L., et al. (2004). Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat. Pain 107, 33-40. doi: 10.1016/j.pain.2003.09.003
48. Fox, M. D., Snyder, A. Z., Vincent, J. L., Corbetta, M., Van Essen, D. C., and Raichle, M. E. (2005). The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc. Natl. Acad. Sci. U S A 102, 9673-9678. doi: 10.1073/pnas.0504136102
49. Franklin, K. B. J. (1998). Analgesia and abuse potential: an accidental association or a common substrate? Pharmacol. Biochem. Behav. 59, 993-1002. doi: 10.1016/s0091-3057(97)00535-2
50. Frodl, T., Schaub, A., Banac, S., Charypar, M., Jäger, M., Kümmler, P., et al. (2006). Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J. Psychiatry Neurosci. 31, 316-323.
51. Gálvez, V., O'Keefe, E., Cotiga, L., Leyden, J., Harper, S., Glue, P., et al. (2014). Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report. Biol. Psychiatry doi: 10.1016/j.biopsych.2013.12.010. [Epub ahead of print].
52. Geng, S. J., Liao, F. F., Dang, W. H., Ding, X., Liu, X. D., Cai, J., et al. (2010). Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation. Exp. Neurol. 222, 256-266. doi: 10.1016/j.expneurol.2010.01.003
53. Geraerts, E., Dritschel, B., Kreplin, U., Miyagawa, L., and Waddington, J. (2012). Reduced specificity of negative autobiographical memories in repressive coping. J. Behav. Ther. Exp. Psychiatry 43(Suppl. 1), S32-S36. doi: 10.1016/j.jbtep.2011.05.007
54. Gorenstein, C., de Carvalho, S. C., Artes, R., Moreno, R. A., and Marcourakis, T. (2006). Cognitive performance in depressed patients after chronic use of antidepressants. Psychopharmacology (Berl) 185, 84-92. doi: 10.1007/s00213-005-0274-2
55. Greicius, M. D., Flores, B. H., Menon, V., Glover, G. H., Solvason, H. B., Kenna, H., et al. (2007). Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol. Psychiatry 62, 429-437. doi: 10.1016/j.biopsych.2006.09.020
56. Grimm, S., Ernst, J., Boesiger, P., Schuepbach, D., Boeker, H., and Northoff, G. (2011). Reduced negative BOLD responses in the default-mode network and increased self-focus in depression. World J. Biol. Psychiatry 12, 627-637. doi: 10.3109/15622975.2010.545145
57. Grimm, S., Ernst, J., Boesiger, P., Schuepbach, D., Hell, D., Boeker, H., et al. (2009). Increased self-focus in major depressive disorder is related to neural abnormalities in subcortical-cortical midline structures. Hum. Brain Mapp. 30, 2617-2627. doi: 10.1002/hbm.20693
58. Grosu, I., and Lavand'homme, P. (2010). Use of dexmedetomidine for pain control. F1000 Med. Rep. 2:90. doi: 10.3410/m2-90
59. Guo, W., Liu, F., Zhang, J., Zhang, Z., Yu, L., Liu, J., et al. (2013). Dissociation of regional activity in the default mode network in first-episode, drug-naive major depressive disorder at rest. J. Affect. Disord. 151, 1097-1101. doi: 10.1016/j.jad.2013.09.003
60. Gupta, K., Kshirsagar, S., Chang, L., Schwartz, R., Law, P. Y., Yee, D., et al. (2002). Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res. 62, 4491-4498.
61. Hashmi, J. A., Baliki, M. N., Huang, L., Baria, A. T., Torbey, S., Hermann, K. M., et al. (2013). Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits. Brain 136, 2751-2768. doi: 10.1093/brain/awt211
62. Hayley, S., and Litteljohn, D. (2013). Neuroplasticity and the next wave of antidepressant strategies. Front. Cell. Neurosci. 7:218. doi: 10.3389/fncel.2013.00218
63. Holderbach, R., Clark, K., Moreau, J. L., Bischofberger, J., and Normann, C. (2007). Enhanced long-term synaptic depression in an animal model of depression. Biol. Psychiatry 62, 92-100. doi: 10.1016/j.biopsych.2006.07.007
64. Hölscher, C. (1999). Stress impairs performance in spatial water maze learning tasks. Behav. Brain Res. 100, 225-235. doi: 10.1016/s0166-4328(98)00134-x
65. Höschl, C., and Hajek, T. (2001). Hippocampal damage mediated by corticosteroids-a neuropsychiatric research challenge. Eur. Arch. Psychiatry Clin. Neurosci. 251(Suppl. 2), S81-S88. doi: 10.1007/bf03035134
66. Howren, M. B., Lamkin, D. M., and Suls, J. (2009). Associations of depression with C-reactive protein, IL-1 and IL-6: a meta-analysis. Psychosom. Med. 71, 171-186. doi: 10.1097/psy.0b013e3181907c1b
67. Iannetti, G. D., and Mouraux, A. (2010). From the neuromatrix to the pain matrix (and back). Exp. Brain Res. 205, 1-12. doi: 10.1007/s00221-010-2340-1
68. Jahchan, N. S., Dudley, J. T., Mazur, P. K., Flores, N., Yang, D., Palmerton, A., et al. (2013). A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov. 3, 1364-1377. doi: 10.1158/2159-8290.cd-13-0183
69. Jasmin, L., Tien, D., Weishenker, D., Palmiter, R. D., Green, P. G., Janni, G., et al. (2002). The NK1 receptor mediates both the hyperalgesia and resistance to morphine in mice lacking noradrenaline. Proc. Natl. Acad. Sci. U S A 99, 1029-1034. doi: 10.1073/pnas.012598599
70. Jeanjean, A. P., Moussaoui, S. M., Maloteaux, J. M., and Laduron, P. M. (1995). Interleukin-1 beta induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience 68, 151-157. doi: 10.1016/0306-4522(95)00106-s
71. Jokinen, J., Nordström, A-L., and Nordström, P. (2009). CSF 5-HIAA and DST non-suppression-orthogonal biologic risk factors for suicide in male mood disorder inpatients. Psychiatry Res. 165, 96-102. doi: 10.1016/j.psychres.2007.10.007
72. Kamping, S., Bomba, I. C., Kanske, P., Diesch, E., and Flor, H. (2013). Deficient modulation of pain by a positive emotional context in fibromyalgia patients. Pain 154, 1846-1855. doi: 10.1016/j.pain.2013.06.003
73. Kawasaki, Y., Kumamoto, E., Furue, H., and Yoshimura, M. (2003). Alpha 2 adrenoceptor-mediated presynaptic inhibition of primary afferent glutamatergic transmission in rat substantia gelatinosa neurons. Anesthesiology 98, 682-689. doi: 10.1097/00000542-200303000-00016
74. Klauenberg, S., Maier, C., Assion, H.-J., Hoffmann, A., Krumova, E. K., Magerl, W., et al. (2008). Depression and changed pain perception: hints for a central disinhibition mechanism. Pain 140, 332-343. doi: 10.1016/j.pain.2008.09.003
75. Klossika, I., Flor, H., Kamping, S., Bleichhardt, G., Trautmann, N., Treede, R. D., et al. (2006). Emotional modulation of pain: a clinical perspective. Pain 124, 264-268. doi: 10.1016/j.pain.2006.08.007
76. Knapp, R. J., Goldenberg, R., Shuck, C., Cecil, A., Watkins, J., Miller, C., et al. (2002). Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model. Eur. J. Pharmacol. 440, 27-35. doi: 10.1016/s0014-2999(02)01338-9
77. Kole, M. H., Swan, L., and Fuchs, E. (2002). The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. Eur. J. Neurosci. 16, 807-816. doi: 10.1046/j.1460-9568.2002.02136.x
78. Křikava, K., Dostal, M., Balcar, K., Yamamotova, A., and Rokyta, R. (2007). Clinical stress, emotions and lymphocyte subsets in peripheral blood. Cesk. Psychol. 51, 12-21.
79. Kroenke, K., Theobald, D., Wu, J., Loza, J. K., Carpenter, J. S., and Tu, W. (2010). The association of depression and pain with health-related quality of life, disability and health care use in cancer patients. J. Pain Symptom Manage. 40, 327-341. doi: 10.1016/j.jpainsymman.2009.12.023
80. Kubera, M., Grygier, B., Wrona, D., Rogóż, Z., Roman, A., Basta-Kaim, A., et al. (2011). Stimulatory effect of antidepressant drug pretreatment on progression of B16F10 melanoma in high-active male and female C57BL/6J mice. J. Neuroimmunol. 240-241, 34-44. doi: 10.1016/j.jneuroim.2011.09.006
81. Latremoliere, A., and Woolf, C. J. (2009). Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain 10, 895-926. doi: 10.1016/j.jpain.2009.06.012
82. Lee, R. S. C., Hermens, D. F., Porter, M. A., and Redoblado-Hodge, M. A. (2012). A meta-analysis of cognitive deficits in first-episode major depressive disorder. J. Affect. Disord. 140, 113-124. doi: 10.1016/j.jad.2011.10.023
83. Lemogne, C., Delaveau, P., Freton, M., Guionnet, S., and Fossati, P. (2012). Medial prefrontal cortex and the self in major depression. J. Affect. Disord. 136, e1-e11. doi: 10.1016/j.jad.2010.11.034
84. Li, B., Liu, L., Friston, K. J., Shen, H., Wang, L., Zeng, L., et al. (2013). A treatment-resistant default mode subnetwork in major depression. Biol. Psychiatry 74, 48-54. doi: 10.1016/j.biopsych.2012.11.007
85. Li, N., Lee, B., Liu, R. J., Banasr, M., Dwyer, J. M., Iwata, M., et al. (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959-964. doi: 10.1126/science.1190287
86. Loggia, M. L., Kim, J., Gollub, R. L., Vangel, M. G., Kirsch, I., Kong, J., et al. (2013). Default mode network connectivity encodes clinical pain: an arterial spin labeling study. Pain 154, 24-33. doi: 10.1016/j.pain.2012.07.029
87. Lussier, D., Huskey, A. G., and Portenoy, R. K. (2004). Adjuvant analgesics in cancer pain management. Oncologist 9, 571-591. doi: 10.1634/theoncologist.9-5-571
88. Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., and Neels, H. (1997). Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokines 9, 853-858. doi: 10.1006/cyto.1997.0238
89. Mansour, A. R., Farmer, M. A., Baliki, M. N., and Apkarian, A. V. (2013). Chronic pain: the role of learning and brain plasticity. Restor. Neurol. Neurosci. doi: 10.3233/RNN-139003. [Epub ahead of print].
90. Marchetti, I., Koster, E. H. W., Sonuga-Barke, E. J., and De Raedt, R. (2012). The default mode network and recurrent depression: a neurobiological model of cognitive risk factors. Neuropsychol. Rev. 22, 229-251. doi: 10.1007/s11065-012-9199-9
91. Marsden, W. N. (2013). Synaptic plasticity in depression: molecular, cellular and functional correlates. Prog. Neuropsychopharmacol. Biol. Psychiatry 43, 168-184. doi: 10.1016/j.pnpbp.2012.12.012
92. Martin, K. P., and Wellman, C. L. (2011). NMDA receptor blockade alters stress-induced dendritic remodeling in medial prefrontal cortex. Cereb. Cortex 21, 2366-2373. doi: 10.1093/cercor/bhr021
93. Martínez-Turrillas, R., Del Río, J., and Frechilla, D. (2007). Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugs. Biochem. Biophys. Res. Commun. 353, 750-755. doi: 10.1016/j.bbrc.2006.12.078
94. Melemedjian, O. K., Tillu, D. V., Asiedu, M. N., Mandell, E. K., Moy, J. K., Blute, V. M., et al. (2013). BDNF regulates atypical PKC at spinal synapses to initiate and maintain a centralized chronic pain state. Mol. Pain 9:12. doi: 10.1186/1744-8069-9-12
95. Melzack, R. (1999). From the gate to the neuromatrix. Pain 82(Suppl. 6), S121-S126. doi: 10.1016/s0304-3959(99)00145-1
96. Melzack, R. (2001). Pain and the neuromatrix in the brain. J. Dent. Educ. 65, 1378-1382.
97. Michel, T. M., Frangou, S., Camara, S., Thiemeyer, D., Jecel, J., Tatschner, T., et al. (2008). Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. Eur. Psychiatry 23, 413-420. doi: 10.1016/j.eurpsy.2008.06.001
98. Monleón, S., Vinader-Caerols, C., Arenas, M. C., and Parra, A. (2008). Antidepressant drugs and memory: insights from animal studies. Eur. Neuropsychopharmacol. 18, 235-248. doi: 10.1016/j.euroneuro.2007.07.001
99. Müller, N. (2013). The role of anti-inflammatory treatment in psychiatric disorders. Psychiatr. Danub. 25, 292-298.
100. Müller, N., and Schwarz, M. J. (2007). The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol. Psychiatry 12, 988-1000. doi: 10.1038/sj.mp.4002006
101. Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., et al. (2006). The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 11, 680-684. doi: 10.1038/sj.mp.4001805
102. Murrough, J. W., Iacoviello, B., Neumeister, A., Charney, D. S., and Iosifescu, D. V. (2011). Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies. Neurobiol. Learn. Mem. 96, 553-563. doi: 10.1016/j.nlm.2011.06.006
103. Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., et al. (2013). Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am. J. Psychiatry 170, 1134-1142. doi: 10.1176/appi.ajp.2013.13030392
104. Na, K. S., Lee, K. J., Lee, J. S., Cho, Y. S., and Jung, H. Y. (2014). Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 48, 79-85. doi: 10.1016/j.pnpbp.2013.09.006
105. Nagata, K., Imai, T., Yamashita, T., Tsuda, M., Tozaki-Saitoh, H., and Inoue, K. (2009). Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief. Mol. Pain 5:20. doi: 10.1186/1744-8069-5-20
106. Napadow, V., LaCount, L., Park, K., As-Sanie, S., Clauw, D. J., and Harris, R. E. (2010). Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum. 62, 2545-2555. doi: 10.1002/art.27497
107. Neeb, L., Hellen, P., Boehnke, C., Hoffmann, J., Schuh-Hofer, S., Dirnagl, U., et al. (2011). IL-1β stimulates COX-2 dependent PGE2 synthesis and CGRP release in rat trigeminal ganglia cells. PLoS One 6:e17360. doi: 10.1371/journal.pone.0017360
108. Nery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta-Soares, G. B., Frey, B. N., et al. (2008). Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum. Psychopharmacol. 23, 87-94. doi: 10.1002/hup.912
109. Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., and Monteggia, L. M. (2002). Neurobiology of depression. Neuron 34, 13-25. doi: 10.1016/S0896-6273(02)00653-0
110. Neveu, P. J., and Castanon, N. (1999). "Is there evidence for an effect of antidepressant drugs on immune function, " in Cytokines, Stress and Depression, eds R. Dantzer, E. E. Wollman and R. Yirmiya (New York: Plenum Publishers, Kluwer Academic), 267-228.
111. Nissen, C., Holz, J., Blechert, J., Feige, B., Riemann, D., Voderholzer, U., et al. (2010). Learning as a model for neural plasticity in major depression. Biol. Psychiatry 68, 544-552. doi: 10.1016/j.biopsych.2010.05.026
112. Nolen-Hoeksema, S. (2000). The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. J. Abnorm. Psychol. 109, 504-511. doi: 10.1037//0021-843x.109.3.504
113. Obata, K., and Noguchi, K. (2006). BDNF in sensory neurons and chronic pain. Neurosci. Res. 55, 1-10. doi: 10.1016/j.neures.2006.01.005
114. Ozaktay, A. C., Kallakuri, S., Takebayashi, T., Cavanaugh, J. M., Asik, I., DeLeo, J. A., et al. (2006). Effects of interleukin-1 beta, interleukin-6 and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats. Eur. Spine J. 15, 1529-1537. doi: 10.1007/s00586-005-0058-8
115. Popoli, M., Yan, Z., McEwen, B. S., and Sanacora, G. (2011). The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat. Rev. Neurosci. 13, 22-37. doi: 10.1038/nrn3138
116. Prasertsri, N., Holden, J., Keefe, F. J., and Wilkie, D. J. (2011). Repressive coping style: relationships with depression, pain and pain coping strategies in lung cancer outpatients. Lung Cancer 71, 235-240. doi: 10.1016/j.lungcan.2010.05.009
117. Racagni, R., and Popoli, M. (2008). Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin. Neurosci. 10, 385-400.
118. Radley, J. J., and Morrison, J. H. (2005). Repeated stress and structural plasticity in the brain. Ageing Res. Rev. 4, 271-287. doi: 10.1016/j.arr.2005.03.004
119. Raison, C. L., Borisov, A. S., Majer, M., Drake, D. F., Pagnoni, G., Woolwine, B. J., et al. (2009). Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol. Psychiatry 65, 296-303. doi: 10.1016/j.biopsych.2008.08.010
120. Rhudy, J. L. (2009). The importance of emotional processes in the modulation of pain. Pain 146, 233-234. doi: 10.1016/j.pain.2009.07.003
121. Rittner, H. L., Brack, A., and Stein, C. (2008). Pain and the immune system. Br. J. Anaesth. 101, 40-44. doi: 10.1093/bja/aen078
122. Rokyta, R., Haklova, O., and Yamamotova, A. (2009). Assessment of chronic benign and cancer pain using blood plasma biomarkers. Neuroendocrinol. Lett. 30, 637-642.
123. Rosenblat, J. D., Cha, D. S., Mansur, R. B., and McIntyre, R. S. (2014). Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2014.01.013. [Epub ahead of print].
124. Ruhé, H. G., Mason, N. S., and Schene, A. H. (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol. Psychiatry 12, 331-359. doi: 10.1038/sj.mp.4001949
125. Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S., Allchorne, A., Poole, S., et al. (2001). Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410, 471-475. doi: 10.1038/35068566
126. Sandi, C. (2011). Glucocorticoids act on glutamatergic pathways to affect memory processes. Trends Neurosci. 34, 165-176. doi: 10.1016/j.tins.2011.01.006
127. Sapolsky, R. M. (1985). Glucocorticoid toxicity in the hippocampus: temporal aspects of neuronal vulnerability. Brain Res. 359, 300-305. doi: 10.1016/0006-8993(85)91440-4
128. Schwarz, M. J., Offenbaecher, M., Neumeister, A., and Ackenheil, M. (2003). Experimental evaluation of an altered tryptophan metabolism in fibromyalgia. Adv. Exp. Med. Biol. 527, 265-275. doi: 10.1007/978-1-4615-0135-0_30
129. Scott, J. A., Wood, M., and Flood, P. (2006). The pronociceptive effect of ondansetron in the setting of P-glycoprotein inhibition. Anesth. Analg. 103, 742-746. doi: 10.1213/01.ane.0000228861.80314.22
130. Shi, X., Wang, L., Li, X., Sahbaie, P., Kingery, W. S., and Clark, J. D. (2011). Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1β production in keratinocytes. Anesth. Analg. 113, 175-183. doi: 10.1213/ane.0b013e31821a0258
131. Shors, T. J., Gallegos, R. A., and Breindl, A. (1997). Transient and persistent consequences of acute stress on long-term potentiation (LTP), synaptic efficacy, theta rhythms and bursts in area CA1 of the hippocampus. Synapse 26, 209-217. doi: 10.1002/(sici)1098-2396(199707)26:3<209::aid-syn2>3.0.co;2-b
132. Shulman, G. L., Fiez, J. A., Corbetta, M., Buckner, R. L., Miezen, F. M., and Raichle, M. E. (1997). Common blood flow changes across visual tasks: II. Decreases in cerebral cortex. J. Cog. Neurosci. 9, 648-663. doi: 10.1162/jocn.1997.9.5.648
133. Silva, R., Mesquita, A. R., Bessa, J., Sousa, J. C., Sotiropoulos, I., Leão, P., et al. (2008). Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta. Neuroscience 152, 656-669. doi: 10.1016/j.neuroscience.2007.12.026
134. Simons, L. E., Elman, I., and Borsook, D. (2014). Psychological processing in chronic pain: a neural systems approach. Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2013.12.006. [Epub ahead of print].
135. Siniscalco, D., Giordano, C., Rossi, F., Maione, S., and de Novellis, V. (2011). Role of neurotrophins in neuropathic pain. Curr. Neuropharmacol. 9, 523-529. doi: 10.2174/157015911798376208
136. Smith, M. A., Makino, S., Kvetnansky, R., and Post, R. M. (1995). Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15, 1768-1777.
137. Sos, P., Klirova, M., Novak, T., Kohutova, B., Horacek, J., and Palenicek, T. (2013). Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression. Neuro. Endocrinol. Lett. 34, 287-293.
138. Steingart, A. B., and Cotterchio, M. (1995). Do antidepressants cause, promote, or inhibit cancers? J. Clin. Epidemiol. 48, 1407-1412. doi: 10.1016/0895-4356(95)00545-5
139. Su, H. C., Ma, C. T., Yu, B. C., Chien, Y. C., Tsai, C. C., Huang, W. C., et al. (2012). Glycogen synthase kinase-3β regulates anti-inflammatory property of fluoxetine. Int. Immunopharmacol. 14, 150-156. doi: 10.1016/j.intimp.2012.06.015
140. Supornsilpchai, W., Sanguanrangsirikul, S., Maneesri, S., and Srikiatkhachorn, A. (2006). Serotonin depletion, cortical spreading depression and trigeminal nociception. Headache 46, 34-39. doi: 10.1111/j.1526-4610.2006.00310.x
141. Tagliazucchi, E., Balenzuela, P., Fraiman, D., and Chialvo, D. R. (2010). Brain resting state is disrupted in chronic back pain patients. Neurosci. Lett. 485, 26-31. doi: 10.1016/j.neulet.2010.08.053
142. Telleria-Diaz, A., Schmidt, M., Kreusch, S., Neubert, A. K., Schache, F., Vazquez, E., et al. (2010). Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: involvement of prostaglandins and endocannabinoids. Pain 148, 26-35. doi: 10.1016/j.pain.2009.08.013
143. Tenant, F., and Hermann, L. (2002). Normalization of serum cortisol concentration with opioid treatment of severe chronic pain. Pain Med. 3, 132-134. doi: 10.1046/j.1526-4637.2002.02019.x
144. Tindall, E. (1999). Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results. J. Am. Osteopath. Assoc. 99(Suppl. 11), S13-S17.
145. Torta, R. G., and Munari, J. (2010). Symptom cluster: depression and pain. Surg. Oncol. 19, 155-159. doi: 10.1016/j.suronc.2009.11.007
146. Tuveson, B., Leffler, A. S., and Hansson, P. (2011). Ondansetron, a 5HT3-antagonist, does not alter dynamic mechanical allodynia or spontaneous ongoing pain in peripheral neuropathy. Clin. J. Pain 27, 323-329. doi: 10.1097/ajp.0b013e31820215c5
147. Van Hunsel, F., Wauters, A., Vandoolaeghe, E., Neels, H., Demedts, P., and Maes, M. (1996). Lower total serum protein, albumin and beta-and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments. Psychiatry Res. 65, 159-169. doi: 10.1016/s0165-1781(96)03010-7
148. van Steenbergen, H., Booij, L., Band, G. P., Hommel, B., and van der Does, A. J. (2012). Affective regulation of cognitive-control adjustments in remitted depressive patients after acute tryptophan depletion. Cogn. Affect. Behav. Neurosci. 12, 280-286. doi: 10.3758/s13415-011-0078-2
149. Walker, A. J., Card, T., Bates, T. E., and Muir, K. (2011). Tricyclic antidepressants and the incidence of certain cancers: a study using the GPRD. Br. J. Cancer 104, 193-197. doi: 10.1038/sj.bjc.6605996
150. Walker, A. J., Grainge, M., Bates, T. E., and Card, T. R. (2012). Survival of glioma and colorectal cancer patients using tricyclic antidepressants post-diagnosis. Cancer Causes Control 23, 1959-1964. doi: 10.1007/s10552-012-0073-0
151. Wang, X., Hou, Z., Yuan, Y., Hou, G., Liu, Y., Li, H., et al. (2011). Association study between plasma GDNF and cognitive function in late-onset depression. J. Affect. Disord. 132, 418-421. doi: 10.1016/j.jad.2011.03.043
152. Wang, Y., Zhang, X., Guo, Q. L., Zou, W. Y., Huang, C. S., and Yan, J. Q. (2010). Cyclooxygenase inhibitors suppress the expression of P2X(3) receptors in the DRG and attenuate hyperalgesia following chronic constriction injury in rats. Neurosci. Lett. 478, 77-81. doi: 10.1016/j.neulet.2010.04.069
153. Warner-Schmidt, J. L., and Duman, R. S. (2006). Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 16, 239-249. doi: 10.1002/hipo.20156
154. Watanabe, Y., Gould, E., Cameron, H. A., Daniels, D. C., and McEwen, B. S. (1992). Phenytoin prevents stress-and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus 2, 431-435. doi: 10.1002/hipo.450020410
155. Wattiez, A. S., Libert, F., Privat, A. M., Loiodice, S., Fialip, J., Eschalier, A., et al. (2011). Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain? Br. J. Pharmacol. 163, 792-803. doi: 10.1111/j.1476-5381.2011.01297.x
156. Wei, F., Dubner, R., Zou, S., Ren, K., Bai, G., Wei, D., et al. (2010). Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J. Neurosci. 30, 8624-8636. doi: 10.1523/jneurosci.5389-09.2010
157. Wei, T., Guo, T. Z., Li, W. W., Hou, S., Kingery, W. S., and Clark, J. D. (2012). Keratinocyte expression of inflammatory mediators plays a crucial role in substance P-induced acute and chronic pain. J. Neuroinflammation 9:181. doi: 10.1186/1742-2094-9-181
158. Wenbin, G., Feng, L., Zhimin, X., Keming, G., Zhening, L., Changqing, X., et al. (2013). Abnormal resting-state cerebellar-cerebral functional connectivity in treatment-resistant depression and treatment sensitive depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 44, 51-57. doi: 10.1016/j.pnpbp.2013.01.010
159. Wiech, K., Ploner, M., and Tracey, I. (2008). Neurocognitive aspects of pain perception. Trends Cogn. Sci. 12, 306-313. doi: 10.1016/j.tics.2008.05.005
160. Wood, P. B. (2006). Mesolimbic dopaminergic mechanisms and pain control. Pain 120, 230-234. doi: 10.1016/j.pain.2005.12.014
161. Woolley, C. S., Gould, E., and McEwen, B. S. (1990). Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531, 225-231. doi: 10.1016/0006-8993(90)90778-a
162. Xueling, Z., Xiang, W., Jin, X., Jian, L., Mingtian, Z., Wei, W., et al. (2012). Evidence of a dissociation pattern in resting-state default mode network connectivity in first-episode, treatment-naive major depression patients. Biol. Psychiatry 71, 611-617. doi: 10.1016/j.biopsych.2011.10.035
163. Yamamotová, A., Hrubá, L., Schutová, B., Rokyta, R., and Šlamberová, R. (2011). Perinatal effect of methamphetamine on nociception in adult Wistar rats. Int. J. Dev. Neurosci. 29, 85-92. doi: 10.1016/j.ijdevneu.2010.08.004
164. Yamamotová, A., and Šlamberová, R. (2012). Behavioral and antinociceptive effects of different psychostimulant drugs in prenatally methamphetamine-exposed rats. Physiol. Res. 61(Suppl. 2), S139-S147.
165. Yaron, I., Shirazi, I., Judovich, R., Levartovsky, D., Caspi, D., and Yaron, M. (1999). Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2 and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum. 42, 2561-2568. doi: 10.1002/1529-0131(199912)42:12<2561::AID-ANR8>3.0.CO;2-U
166. Zarate, C. A. Jr., Singh, J. B., Quiroz, J. A., De Jesus, G., Denicoff, K. K., Luckenbaugh, D. A., et al. (2006). A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am. J. Psychiatry 163, 153-155. doi: 10.1176/appi.ajp.163.1.153
167. Zhang, J.-M., and An, J. (2007). Cytokines, inflammation and pain. Int. Anesthesiol. Clin. 45, 27-37. doi: 10.1097/AIA.0b013e318034194e
168. Zhu, X., Wang, X., Xiao, J., Liao, J., Zhong, M., Wang, W., et al. (2012). Evidence of a dissociation pattern in resting-state default mode network connectivity in first-episode, treatment-naive major depression patients. Biol. Psychiatry 71, 611-617. doi: 10.1016/j.biopsych.2011.10.035